+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Laennec Fellow in Training (FIT) Clinician Award

American Heart Association

The Laennec Fellow in Training (FIT) Clinician Award recognizes the importance of clinical acumen, inductive analytic skills, and teaching ability in future academic cardiologists.

This prestigious award honors cardiovascular fellows-in-training who demonstrate outstanding clinical judgment, diagnostic reasoning, and educational skill through the presentation of a real patient case. It is specifically designed to highlight the role of clinical excellence in patient care, rather than research.

Application Criteria

Submit an abstract to one of the Scientific Sessions categories sponsored by the American Heart Association Scientific Council supporting this award. Make sure that your abstract has been submitted in a category listed under the award for which you want to apply (PDF).
Only one abstract per candidate will be considered.
Applicants must provide their unpublished case study at the time of application. The applicant must be the first and presenting author, although the case study may have co-authors.
The presenting author of an accepted abstract must be registered for Scientific Sessions.
An individual may not compete for other award competitions during the same scientific meeting.
Previous winners, runner ups, and finalists are not eligible to re-enter the competition in subsequent years.
Applicants must adhere to the American Heart Association Embargo Policy.
The work covered by the abstract must not have been presented at a national or international meeting or world congress before the date and time of presentation at Scientific Sessions. The abstract must comply with the American Heart Association Abstract Submission Guidelines as outlined by the Scientific Sessions Program Committee.
Notwithstanding the above, the American Heart Association Officers have the discretion to determine eligibility for the award in extraordinary circumstances when there is an issue relating to American Heart Association policy, positions or other potentially controversial issue relating to the positioning or perception of the American Heart Association.

Timeline

June 4, 2026, 9 a.m. (CT) – Deadline to submit an abstract to Scientific Sessions 2026.
June 8, 2026 – Deadline to have an active American Heart Association professional membership. Please note that membership processing may take 3–5 days; do not wait until the proposal deadline to Join or Renew.
June 10, 2026, 6 p.m. (CT) – Deadline to apply for the award in the Council Awards Application System.
August 2026 – Applicants are notified of their award status (selected or not selected). Only those with an accepted abstract will be considered for selection.

Prize

Finalists for the early career investigator award competitions will be announced in August and will present their research results at Scientific Sessions in November. Each finalist must present their abstract in-person at Scientific Sessions. Virtual presentations or an alternate (proxy) presenter will not be permitted and will result in disqualification from the award.

Each finalist will receive one complimentary ticket to and recognition at the council dinner, where they will be presented with an engraved award plaque. The winner will be announced at the dinner.
The winner will receive a $2,500 honorarium; up to four remaining finalists will each receive a $1,500 honorarium.
All case presentations may be submitted with guaranteed evaluation by Circulation Cardiovascular Case Series editors.

AI Based Application Success Predictor

1. Direct Relevance to Cardiovascular / Cerebrovascular / Vascular / Heart- or Circulation-related Disease or Physiology

The research question must be clearly tied to cardiovascular or related disease/biology (heart disease, stroke, vascular biology, risk factors, prevention, therapy, epidemiology, etc.).

Whether basic science, translational, clinical or public-health — the link to cardiovascular health must be explicit and central.
Predictor: Tight, explicit cardiovascular relevance — generic biomedical proposals rarely compete well.

2. Scientific Merit, Innovation & Potential to Advance the Field

Novel hypotheses, new therapeutic or diagnostic approaches, underexplored mechanisms, or prevention strategies tend to be highly valued.

Projects that promise to yield important insights into disease pathophysiology, risk factors, prevention, or new treatment strategies are prioritized.
Predictor: High innovation + potential for significant impact increases funding likelihood.

3. Feasible, Well-Designed Study with Realistic Aims & Methods

Given variability in grant size (some are modest seed grants, others larger), successful applications often have focused aims (2–4), a clear methodological plan, and a realistic timeline.

For clinical or population research: well-defined endpoints, appropriate sample size, statistical plan, and feasible recruitment/ follow-up.

For basic/translational research: robust design, appropriate models, controls, reproducibility plans, ethical compliance if human/animal subjects.
Predictor: Well-scoped, methodologically rigorous, feasible studies — rather than overly ambitious ones — tend to do best.

4. Investigator Credentials, Institutional Support & Resources (Especially for Early-Career/Fellowships)

For early-career investigators: mentorship, training environment, access to necessary infrastructure (labs, patient cohorts, imaging, data resources) is important.

For experienced investigators: previous record in cardiovascular research, publications, and proof of capacity to deliver.

Institutional commitment (protected time, core facilities, collaborative environment) gives reviewers confidence in feasibility.
Predictor: Strong team + institutional backing increases competitiveness.

5. Translational or Public Health Potential — Not Just Academic Interest

AHA values research that can lead to improved prevention, diagnostics, therapies, or population health impact, not just basic science.

Especially for clinical or epidemiologic proposals: potential for influence on practice, guidelines, public-health policy, or risk reduction.
Predictor: Clear path to translation or public health impact boosts an application's value.

6. Preliminary Data or Strong Rationale (When Required)

For more ambitious proposals, having pilot data or preliminary results helps — establishes feasibility and reduces risk.

For less data-heavy proposals (e.g., early-phase or exploratory studies), a strong rationale, literature support, and sound hypothesis may suffice — but logic must be tight.
Predictor: Demonstrated feasibility or well-supported rationale increases credibility.

7. Good Grant Writing — Clarity, Structure, Significance & Impact — + Realistic Budget

Well-structured aims, clear background & significance, logical methods, realistic budget, timeline, deliverables.

For smaller grants: budgets need to match project scope — no over-ambitious aims with limited funds.

Clear statement of impact — scientific, clinical, or public health.
Predictor: Strong narrative + realistic budgeting + clear impact improves chances substantially.

8. Diversity, Equity, and Inclusion (Especially for Population/Clinical Research)

Given cardiovascular disease burden varies by demographic, proposals addressing health disparities, risk factors in underrepresented populations, or equitable access to care are often viewed favorably.

Inclusion of diverse populations and a plan for equitable recruitment/impact enhances public-health relevance.
Predictor: Focus on equity or underserved populations can strengthen proposals — especially for population-based or prevention studies.

9. Path Toward Future Funding, Translation or Long-Term Impact

Seed or pilot grants should ideally position the project for follow-on funding (bigger grants, multicenter studies, clinical trials) or real-world translation.

Reviewers often assess scalability and long-term benefit, not just immediate results.
Predictor: Projects that show a clear plan for growth or translation — beyond the initial funding — tend to fare better.

🚫 Common Pitfalls & What Weak Applications Look Like

Vague cardiovascular link — proposals that are generic biomedical but without clear heart/vascular relevance

Overly ambitious aims relative to funding or resources, unrealistic timelines

Weak methodology, vague endpoints, poor feasibility, inadequate institutional support

Lack of translational or public-health relevance — purely descriptive without clear impact

Poor grant writing: unclear structure, weak significance statement, ill-justified budget

🎯 What This Means — If You Plan to Apply to AHA

Begin with a clear cardiovascular-focused research question (disease, physiology, prevention or therapy)

Design a focused, realistic study (2–4 aims max, methods matched to resources, ethical plan if needed)

Ensure you have site/institutional support, mentorship (if early career), and resource access

Emphasize innovation and potential impact — scientific, clinical, or public health/ population health

If appropriate, address diversity and health equity, especially in population-based or prevention studies

Write a clear, structured, compelling proposal — background, significance, aims, methods, budget, impact

For seed-level grants: plan for future funding or translational steps — make your proposal a stepping stone

Budget realistically, and request only what is necessary to complete the aims

Specialties

Cardiovascular Diseases

Eligibility Requirements

Applicants must be active in research and within 10 years of completion of terminal degree or highest certificate (e.g., MSc, MD or equivalent), or within 10 years of completing medical fellowship, or clinical training as of the award application date. Current fellows in training who are members of the council are eligible to apply.
Applicants must be members of the American Heart Association Scientific Council sponsoring this award. Your council affiliation will be validated during the application process. Membership must be completed online. Please note that membership processing may take 3–5 days; do not wait until the proposal deadline to Join or Renew.

Sponsor Details

Sponsor Institute/Organizations: American Heart Association

Sponsor Type: Corporate/Non-Profit

Address: 7272 Greenville Ave. Dallas, TX 75231

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity